Trinity Biotech (TRIB) Equity Average (2021 - 2022)
Trinity Biotech recorded quarterly Equity Average of $2.2 million in Q4 2022, down 80.15% quarter-over-quarter from $11.2 million in Q3 2022, and up 807.74% year-over-year from $245500.0 in Q4 2021.
Trinity Biotech's Equity Average history runs 2 years deep, the most recent figure standing at $2.2 million for Q4 2022.
- In Q4 2022, Equity Average rose 807.74% year-over-year to $2.2 million; the TTM figure through Dec 2022 stood at $2.2 million (up 807.74% YoY), while the FY2025 annual figure was -$53.6 million, down 81.23% from the prior year.
- Equity Average came in at $2.2 million for Q4 2022 at Trinity Biotech, down from $11.2 million in the prior quarter.
- In the past five years, Equity Average ranged from a high of $11.2 million in Q3 2022 to a low of -$3.3 million in Q1 2022.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 52.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 22.70 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 49.03 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 25.17 Bn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 10.33 Bn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 2.85 Bn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 10.53 Bn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 7.18 Bn |
| 10 | Trinity Biotech | 28,000.00 | -5.11 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2022 | 2.23 Mn |
| Sep 30, 2022 | 11.23 Mn |
| Jun 30, 2022 | 4.77 Mn |
| Mar 31, 2022 | -3.30 Mn |
| Dec 31, 2021 | 245,500.00 |
| Sep 30, 2021 | 157,000.00 |
| Jun 30, 2021 | -311,500.00 |
| Mar 31, 2021 | -662,500.00 |